With reference to earlier letters dated July 3, 2023 and September 12, 2023 informing about acquisition of certain marketing and manufacturing related authorisations, Aurobindo Pharma has informed that the aforementioned acquisition has been completed on December 15, 2023.
The above information is a part of company’s filings submitted to BSE.